Non-invasive vagus nerve stimulation is beneficial in chronic paroxysmal hemicrania.
作者信息
Kamourieh Salwa, Lagrata Susie, Matharu Manjit Singh
机构信息
Headache Group, The National Hospital for Neurology and Neurosurgery, London, UK.
Headache Group, The National Hospital for Neurology and Neurosurgery, London, UK
出版信息
J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):1072-1074. doi: 10.1136/jnnp-2018-319538. Epub 2019 Feb 1.
Abstract
摘要
相似文献
1
Non-invasive vagus nerve stimulation is beneficial in chronic paroxysmal hemicrania.
J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):1072-1074. doi: 10.1136/jnnp-2018-319538. Epub 2019 Feb 1.
2
Noninvasive Vagus Nerve Stimulation for Treatment of Indomethacin-Sensitive Headaches.
JAMA Neurol. 2017 Oct 1;74(10):1266-1267. doi: 10.1001/jamaneurol.2017.2122.
3
Non-invasive vagus nerve stimulation for the management of refractory primary chronic headaches: A real-world experience.
Cephalalgia. 2018 Jun;38(7):1276-1285. doi: 10.1177/0333102417731349. Epub 2017 Sep 12.
4
Chronic paroxysmal hemicrania, hemicrania continua and SUNCT: the fate of the three first described cases.
J Headache Pain. 2006 Jun;7(3):151-6. doi: 10.1007/s10194-006-0303-5. Epub 2006 Jun 22.
5
Occipital Nerve Stimulation for Medically Refractory Chronic Paroxysmal Hemicrania.
Headache. 2017 Nov;57(10):1610-1613. doi: 10.1111/head.13187. Epub 2017 Oct 5.
6
A New Treatment Option for Children With Refractory Chronic Paroxysmal Hemicranias: Occipital Nerve Stimulation.
Pediatr Neurol. 2021 Dec;125:18-19. doi: 10.1016/j.pediatrneurol.2021.09.010. Epub 2021 Sep 24.
7
Chronic paroxysmal hemicrania: from the index patient to the disease.
Curr Pain Headache Rep. 2006 Aug;10(4):295-301. doi: 10.1007/s11916-006-0035-x.
8
Paroxysmal hemicrania, SUNCT, and hemicrania continua.
Semin Neurol. 2006 Apr;26(2):260-70. doi: 10.1055/s-2006-939926.
9
Indomethacin-Responsive Headache Disorders.
Continuum (Minneap Minn). 2024 Apr 1;30(2):488-497. doi: 10.1212/CON.0000000000001409.
10
Paroxysmal hemicrania in children--symptoms, diagnostic criteria, therapy and outcome.
Cephalalgia. 2009 Aug;29(8):873-82. doi: 10.1111/j.1468-2982.2008.01813.x. Epub 2009 Feb 19.
引用本文的文献
1
Update on Neuromodulation for Migraine and Other Primary Headache Disorders: Recent Advances and New Indications.
Curr Pain Headache Rep. 2025 Feb 15;29(1):47. doi: 10.1007/s11916-024-01314-7.
2
Transcutaneous vagus nerve stimulation as a pain modulator in knee osteoarthritis: a randomized controlled clinical trial.
BMC Musculoskelet Disord. 2025 Jan 20;26(1):68. doi: 10.1186/s12891-025-08288-6.
3
Neuromodulation for Headache Management in Pregnancy.
Curr Pain Headache Rep. 2025 Jan 7;29(1):14. doi: 10.1007/s11916-024-01344-1.
4
Non-invasive neuromodulation of the cervical vagus nerve in rare primary headaches.
Front Pain Res (Lausanne). 2023 Mar 13;4:1062892. doi: 10.3389/fpain.2023.1062892. eCollection 2023.
本文引用的文献
1
Noninvasive Vagus Nerve Stimulation for Treatment of Indomethacin-Sensitive Headaches.
JAMA Neurol. 2017 Oct 1;74(10):1266-1267. doi: 10.1001/jamaneurol.2017.2122.
2
Vagus nerve stimulation suppresses acute noxious activation of trigeminocervical neurons in animal models of primary headache.
Neurobiol Dis. 2017 Jun;102:96-104. doi: 10.1016/j.nbd.2017.03.004. Epub 2017 Mar 9.
3
The International Classification of Headache Disorders, 3rd edition (beta version).
Cephalalgia. 2013 Jul;33(9):629-808. doi: 10.1177/0333102413485658.
4
Paroxysmal hemicrania: a prospective clinical study of 31 cases.
Brain. 2008 Apr;131(Pt 4):1142-55. doi: 10.1093/brain/awn010. Epub 2008 Feb 5.
5
Indomethacin-responsive headache syndromes.
Curr Pain Headache Rep. 2004 Feb;8(1):19-26. doi: 10.1007/s11916-004-0036-6.
Zotero 插件